Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Jordan

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
AIDS Research and Therapy|September 27, 2025
High HIV viral suppression among adults receiving WHO-recommended first-line dolutegravir-based antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis of programmatic evidenceAmalia Girón-Callejas, Rolando Lorenzana, Michael Pickles, et al.
Journal of the International AIDS Society|September 16, 2020
HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimatesSoo-Yon Rhee, Seble G Kassaye, Geoffrey Barrow, et al.
Journal of the International AIDS Society|December 28, 2020
Prevalence of pretreatment HIV drug resistance in key populations: a systematic review and meta-analysisVirginia Macdonald, Lawrence Mbuagbaw, Michael R Jordan, et al.
AIDS (London, England)|January 29, 2014
Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiationValentina Cambiano, Silvia Bertagnolio, Michael R Jordan, et al.
Plos One|April 14, 2022
Predictors of loss to follow-up from HIV antiretroviral therapy in NamibiaSteven Y Hong, Anna Winston, Nicholus Mutenda, et al.
Plos One|August 21, 2012
Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoringViktor von Wyl, Valentina Cambiano, Michael R Jordan, et al.
The Journal of Infectious Diseases|March 23, 2017
Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub-Saharan AfricaAndrew N Phillips, John Stover, Valentina Cambiano, et al.
Journal of Virological Methods|May 11, 2010
Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populationsMichael R Jordan, Mary Kearney, Sarah Palmer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countriesDiane E Bennett, Michael R Jordan, Silvia Bertagnolio, et al.
Antiviral Therapy|August 18, 2012
Determinants of HIV drug resistance and public health implications in low- and middle-income countriesSilvia Bertagnolio, Andrea De Luca, Marco Vitoria, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
AIDS Research and Therapy|September 27, 2025
High HIV viral suppression among adults receiving WHO-recommended first-line dolutegravir-based antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis of programmatic evidenceAmalia Girón-Callejas, Rolando Lorenzana, Michael Pickles, et al.
Journal of the International AIDS Society|September 16, 2020
HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimatesSoo-Yon Rhee, Seble G Kassaye, Geoffrey Barrow, et al.
Journal of the International AIDS Society|December 28, 2020
Prevalence of pretreatment HIV drug resistance in key populations: a systematic review and meta-analysisVirginia Macdonald, Lawrence Mbuagbaw, Michael R Jordan, et al.
AIDS (London, England)|January 29, 2014
Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiationValentina Cambiano, Silvia Bertagnolio, Michael R Jordan, et al.
Plos One|April 14, 2022
Predictors of loss to follow-up from HIV antiretroviral therapy in NamibiaSteven Y Hong, Anna Winston, Nicholus Mutenda, et al.
Plos One|August 21, 2012
Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoringViktor von Wyl, Valentina Cambiano, Michael R Jordan, et al.
The Journal of Infectious Diseases|March 23, 2017
Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub-Saharan AfricaAndrew N Phillips, John Stover, Valentina Cambiano, et al.
Journal of Virological Methods|May 11, 2010
Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populationsMichael R Jordan, Mary Kearney, Sarah Palmer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countriesDiane E Bennett, Michael R Jordan, Silvia Bertagnolio, et al.
Antiviral Therapy|August 18, 2012
Determinants of HIV drug resistance and public health implications in low- and middle-income countriesSilvia Bertagnolio, Andrea De Luca, Marco Vitoria, et al.
Pageof 11